Buy Narayana Hrudayalaya; target of Rs 585: ICICI Direct
ICICI Direct is bullish on Narayana Hrudayalaya recommended buy rating on the stock with a target price of Rs 585 in its research report dated Jun 03, 2021.
June 10, 2021 / 12:19 PM IST
ICICI Direct's research report on Narayana Hrudayalaya
Narayana posted strong QoQ, YoY growth, better than our estimates across all fronts. Revenues grew 12.8% YoY to Rs 838 crore with India sales growing 9.5% YoY to Rs 700 crore. Revenues from Cayman operations grew 30.6% YoY to US$18.5 million due to lower base and strong ARPOB traction. On the EBITDA front, margins expanded 399 bps to 16.9% amid lower employee & other expenditure. Subsequently, EBITDA grew 47.7% YoY to Rs 141 crore. Adjusted PAT for the quarter was at Rs 68 crore, nearly 3x Q4FY20.
We maintain BUY recommendation and arrive at an SOTP target price of Rs 585 (earlier Rs 545) by valuing matured hospitals and Cayman Islands at 16x FY23E EV/EBITDA, new hospitals at 1.5x and other business at 1x FY23E EV/sales.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.